沃华医药
(002107)
| 流通市值：37.48亿 | | | 总市值：37.98亿 |
| 流通股本：5.70亿 | | | 总股本：5.77亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 392,959,237.05 | 431,483,318.34 | 404,025,624.09 | 344,774,257.71 |
| 应收票据及应收账款 | 66,207,856.98 | 69,976,290.14 | 69,102,264.71 | 66,522,465.53 |
| 其中：应收票据 | 2,993,178.59 | 2,446,864.21 | 2,707,937.99 | 3,395,801.26 |
| 应收账款 | 63,214,678.39 | 67,529,425.93 | 66,394,326.72 | 63,126,664.27 |
| 应收款项融资 | 1,337,364.52 | 2,470,850.79 | 3,496,997.75 | 4,477,892.05 |
| 预付款项 | 3,164,811.6 | 2,983,407.61 | 3,839,211.85 | 2,908,012.71 |
| 其他应收款合计 | 2,173,249.71 | 1,683,658.87 | 1,815,635.33 | 11,793,033.61 |
| 存货 | 84,821,049.64 | 101,298,840.45 | 98,562,497.96 | 107,134,043.15 |
| 其他流动资产 | 4,599,161.85 | 4,760,440.04 | 4,918,796.93 | 5,508,698 |
| 流动资产合计 | 555,262,731.35 | 614,656,806.24 | 585,761,028.62 | 543,118,402.76 |
| 非流动资产: | | | | |
| 投资性房地产 | 17,113,373.01 | 17,294,061.36 | 17,474,749.71 | 17,655,438.06 |
| 固定资产 | 332,374,093.07 | 339,479,026.23 | 346,575,022.11 | 353,401,190.89 |
| 使用权资产 | 1,357,173.47 | 1,589,862.62 | 1,822,551.77 | 2,055,420.92 |
| 无形资产 | 34,639,170.61 | 34,938,625.66 | 35,244,721.39 | 35,564,098.09 |
| 商誉 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 | 32,508,664.53 |
| 递延所得税资产 | 418,249.48 | 377,525.82 | 381,857.21 | 1,034,582.72 |
| 其他非流动资产 | 20,690 | 10,000 | 10,000 | 392,700 |
| 非流动资产合计 | 418,431,414.17 | 426,197,766.22 | 434,017,566.72 | 442,612,095.21 |
| 资产总计 | 973,694,145.52 | 1,040,854,572.46 | 1,019,778,595.34 | 985,730,497.97 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 34,188,414.73 | 50,754,116.66 | 46,088,085.67 | 41,965,269.31 |
| 其中：应付票据 | - | - | - | 0 |
| 应付账款 | 34,188,414.73 | 50,754,116.66 | 46,088,085.67 | 41,965,269.31 |
| 合同负债 | 2,608,388.98 | 2,421,581.92 | 2,364,396.69 | 6,850,350.2 |
| 应付职工薪酬 | 7,032,787.88 | 7,520,734.01 | 7,301,744.32 | 9,262,176.41 |
| 应交税费 | 17,453,183.57 | 12,568,613.01 | 13,710,316.88 | 11,378,405.47 |
| 其他应付款合计 | 38,518,317.65 | 40,613,301.04 | 35,986,809.46 | 33,720,814.11 |
| 一年内到期的非流动负债 | 911,849.87 | 903,388.13 | 895,018.37 | 1,022,029.43 |
| 其他流动负债 | 146,959,178.99 | 147,529,059.32 | 152,675,135.81 | 138,090,788.41 |
| 流动负债合计 | 247,672,121.67 | 262,310,794.09 | 259,021,507.2 | 242,289,833.34 |
| 非流动负债: | | | | |
| 租赁负债 | 513,331.6 | 789,715.59 | 1,063,684.4 | 1,154,729.92 |
| 长期应付职工薪酬 | 90,032.5 | 121,788.49 | 167,031.76 | 209,968.36 |
| 预计负债 | - | - | - | 0 |
| 递延收益 | 12,766,836.02 | 13,499,465.83 | 14,232,481 | 14,965,496.17 |
| 递延所得税负债 | 3,932,184.98 | 3,940,969.81 | 4,167,510.92 | 4,176,295.75 |
| 非流动负债合计 | 17,302,385.1 | 18,351,939.72 | 19,630,708.08 | 20,506,490.2 |
| 负债合计 | 264,974,506.77 | 280,662,733.81 | 278,652,215.28 | 262,796,323.54 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 577,209,600 | 577,209,600 | 577,209,600 | 577,209,600 |
| 盈余公积 | 46,272,148.97 | 46,272,148.97 | 46,272,148.97 | 46,272,148.97 |
| 未分配利润 | 68,616,396.78 | 118,562,949.38 | 96,746,369.31 | 73,886,556.43 |
| 归属于母公司股东权益合计 | 692,098,145.75 | 742,044,698.35 | 720,228,118.28 | 697,368,305.4 |
| 少数股东权益 | 16,621,493 | 18,147,140.3 | 20,898,261.78 | 25,565,869.03 |
| 股东权益合计 | 708,719,638.75 | 760,191,838.65 | 741,126,380.06 | 722,934,174.43 |
| 负债和股东权益合计 | 973,694,145.52 | 1,040,854,572.46 | 1,019,778,595.34 | 985,730,497.97 |
| 公告日期 | 2025-10-18 | 2025-07-22 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |